<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03050476</url>
  </required_header>
  <id_info>
    <org_study_id>NUH-ALS-2015-04</org_study_id>
    <nct_id>NCT03050476</nct_id>
  </id_info>
  <brief_title>Preventing Systemic Inflammation After Cardiac Surgery With Alkaline Phosphatase</brief_title>
  <acronym>APPIRED-III</acronym>
  <official_title>Preventing Oxidative Stress-induced Ischemic Injury- and Systemic Inflammation Complications During and After Invasive Cardiac Surgery With Alkaline Phosphatase (APPIRED III)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Alloksys Life Sciences B.V.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Aix Scientifics</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Singapore Clinical Research Institute</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Alloksys Life Sciences B.V.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Study should demonstrate that alkaline phosphatase reduces the incidence and extent of acute
      kidney injury after cardiopulmonary bypass (CPB) as defined by the AKIN criteria.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      After cardiac surgery under cardiopulmonary bypass (CPB) patients often show impairments of
      the immune system. Compared to placebo, CPB patients given alkaline phosphatase will have
      reduced composite endpoint of acute kidney injury, late extubation, gastrointestinal or
      neurological complications or death within 30 days.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">February 2017</start_date>
  <completion_date type="Anticipated">February 2022</completion_date>
  <primary_completion_date type="Anticipated">February 2019</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of patients with acute kidney injury</measure>
    <time_frame>30 days</time_frame>
    <description>AKIN criteria: Rise in serum creatinine of by 0.3 mg/dl or 26 µmol/L in 48 hours/ a percentage increase in the serum creatinine concentration of more than 50 percent or a drop in urine output to 0.5 ml/kg/hour for 6 hours</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>cost-related outcome</measure>
    <time_frame>30 days</time_frame>
    <description>Cost (SGD) incurred on renal replacement therapy, ICU and hospital stay</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>levels of a set of inflammatory markers</measure>
    <time_frame>24 hours</time_frame>
    <description>IL-6, IL-8, IL-10, TNF-alpha</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">1050</enrollment>
  <condition>Systemic Inflammation</condition>
  <condition>Cardiopulmonary-bypass</condition>
  <arm_group>
    <arm_group_label>bRESCAP</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Bolus of 1000 IU of bovine intestinal alkaline phosphatase on induction of anaesthesia, followed by an infusion of 9000 IU over the next 24 hours.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Bolus of of media on induction of anaesthesia, followed by an infusion of media over the next 24 hours.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>bRESCAP</intervention_name>
    <description>intravenous application before, during, and for 24 hours after heart surgery</description>
    <arm_group_label>bRESCAP</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>placebo</intervention_name>
    <description>intravenous application before, during, and for 24 hours after heart surgery</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Undergoing cardiac surgery with planned cardiopulmonary bypass

          -  Additive Euroscore2 &gt; 5

          -  Ability to provide informed consent (not incapacitated)

          -  Patients of reproductive age can use any contraceptive method

        Exclusion Criteria:

          -  Already on renal replacement therapy

          -  Patients with chronic kidney disease defined as urinary albumin excretion of ≥30
             mg/day, or equivalent or estimated glomerular filtration rate [eGFR] &lt;60 mL/min/1.73
             m2 for &gt; 3 months.

          -  Patients who are pregnant

          -  Concurrent enrollment in another clinical trial

          -  Known allergic reaction to bovine alkaline phosphatase
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ruud Brands, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Alloksys Life Sciences BV . President</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Theodoros Kofidis, Prof.Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>National University Hospital (NUH), Singapore</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ruud Brands, PhD</last_name>
    <phone>+31 30 253 3615</phone>
    <email>ruud@alloksys.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Eike G Fischer, PhD</last_name>
    <phone>+49 241 4500 358</phone>
    <email>eike@aix-scientifics.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>MedUniWien / AKH-Wien</name>
      <address>
        <city>Wien</city>
        <zip>1090</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital ZOL</name>
      <address>
        <city>Genk</city>
        <zip>3600</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Tom Fret, MD</last_name>
      <phone>+32 89 - 32 50 05</phone>
      <email>TomFret@mac.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Klinik für Herzchirurgie, Universitätsklinik</name>
      <address>
        <city>Leipzig</city>
        <zip>04289</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jörg Seeburger, Prof. Dr. med.</last_name>
      <phone>+49 341 865-1421</phone>
      <email>joerg.seeburger@helios-kliniken.de</email>
    </contact>
    <contact_backup>
      <last_name>Anne-Kathrin Funkat, Dr.</last_name>
      <phone>+49 341 865 1571</phone>
      <email>anne-kathrin.funkat@leipzig-heart.de</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Policlinico Gemelli, Institute Cardiology</name>
      <address>
        <city>Roma</city>
        <zip>00168</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Massimo Massetti, Prof.MD</last_name>
      <phone>+39 06 - 3015 - 8762</phone>
      <email>Massimo.Massetti@unicatt.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Catharina Ziekenhuis, Cathreine R&amp;D, Heartcentre</name>
      <address>
        <city>Eindhoven</city>
        <zip>5623 EJ</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>M.E.S.H. Tan, MD</last_name>
      <phone>+31 40 ‐ 239 8360</phone>
      <email>erwin.tan@catharinaziekenhuis.nl</email>
    </contact>
    <contact_backup>
      <last_name>Esther van Dooren</last_name>
      <email>Esther.v.Dooren@catharinaziekenhuis.nl</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Hospital de Santa Marta</name>
      <address>
        <city>Lisboa</city>
        <zip>1169-024</zip>
        <country>Portugal</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>José Fragata, Prof. MD, PhD</last_name>
      <phone>+351 21 359 41 06</phone>
      <email>jigFragata@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Pedro Coelho, MD</last_name>
      <email>pedropirescoelho@gmail.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Almazov Heart Center</name>
      <address>
        <city>St Petersburg</city>
        <zip>197341</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Alexandra Konradi, Prof dr</last_name>
      <phone>+7 812 702-68-16</phone>
      <email>konradi@almazovcentre.ru</email>
    </contact>
    <contact_backup>
      <last_name>Olga Bolsakova, Prof</last_name>
      <phone>+7 (812) 702-37-41</phone>
      <email>oobolshakova@yahoo.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>National University Hospital (NUH),</name>
      <address>
        <city>Singapore</city>
        <zip>119228</zip>
        <country>Singapore</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Theodoros Kofidis, Prof.Dr.</last_name>
      <phone>+65 677 - 22059</phone>
      <email>Theodoros@nuhs.edu.sg</email>
    </contact>
    <contact_backup>
      <last_name>Ram Ramanathan</last_name>
      <email>Ram_Ramanathan@nuhs.edu.sg</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Austria</country>
    <country>Belgium</country>
    <country>Germany</country>
    <country>Italy</country>
    <country>Netherlands</country>
    <country>Portugal</country>
    <country>Russian Federation</country>
    <country>Singapore</country>
  </location_countries>
  <verification_date>February 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 24, 2017</study_first_submitted>
  <study_first_submitted_qc>February 8, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">February 13, 2017</study_first_posted>
  <last_update_submitted>February 8, 2017</last_update_submitted>
  <last_update_submitted_qc>February 8, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">February 13, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>side-effects</keyword>
  <keyword>heart-lung machine</keyword>
  <keyword>alkaline phosphatase</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Inflammation</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

